Academic Center for Evidence Based Sports Medicine (ACES), Amsterdam, The Netherlands; Department of Sports Medicine, The Hague Medical Center, HMC Antoniushove, The Netherlands.
Coronel Institute of Occupational Health, Academic Medical Center/University of Amsterdam, The Netherlands.
J Sci Med Sport. 2018 Oct;21(10):1032-1037. doi: 10.1016/j.jsams.2018.03.010. Epub 2018 Mar 28.
To assess the association between posterior circumflex humeral artery (PCHA) pathology (PCHAP), symptoms and associated risk factors, in elite volleyball players, and to suggest profiles for clinical management and monitoring.
Cross-sectional study.
A questionnaire assessed symptoms of digital ischemia (DI) in the dominant hand and risk factors among 278 elite indoor and beach volleyball players of whom 6.1% (17/278) was diagnosed with PCHAP using ultrasound. Odds Ratios (OR) including 95% confidence intervals (95%CI) were calculated using binary logistic regression.
All 278 players completed the questionnaire. Three participants with PCHAP were symptomatic (18%). Ninety-three of 96 symptomatic participants had no PCHAP (OR=0.39; 95% CI 0.13-1.13). Total years playing volleyball (OR 1.14; 95% CI 1.03-1.25) and age (OR 1.17; 95% CI 1.00-1.29) were dose-response related risk factors: a volleyball career of ≥17 years and age of ≥27 years were associated with a 9-fold and 14-fold increased risk of PCHAP, respectively.
The volleyball career duration and age are dose-response related risk factors for PCHAP among elite indoor and beach volleyball players. DI symptoms are prevalent in a minority of athletes with PCHAP (3/17; 18%). To enable worldwide standardized care for these athletes at risk, four profiles for clinical management and monitoring have been suggested based on questionnaire and ultrasound outcomes.
评估精英排球运动员中旋肱后动脉（PCHA）病变（PCHAP）、症状和相关危险因素之间的关系，并为临床管理和监测提供建议。
横断面研究。
问卷调查评估了 278 名精英室内和沙滩排球运动员中惯用手的指端缺血（DI）症状和危险因素，其中 6.1%（17/278）通过超声诊断为 PCHAP。使用二项逻辑回归计算比值比（OR）及其 95%置信区间（95%CI）。
278 名运动员均完成了问卷调查。3 名 PCHAP 患者有症状（18%）。96 名有症状的参与者中有 93 名无 PCHAP（OR=0.39；95%CI 0.13-1.13）。总排球生涯（OR 1.14；95%CI 1.03-1.25）和年龄（OR 1.17；95%CI 1.00-1.29）呈剂量反应相关的危险因素：排球生涯≥17 年和年龄≥27 岁分别与 PCHAP 的 9 倍和 14 倍风险相关。
排球生涯时间和年龄是精英室内和沙滩排球运动员中 PCHAP 的剂量反应相关危险因素。有 PCHAP 的运动员中，DI 症状仅在少数（3/17；18%）患者中出现。为了能够对这些高危运动员进行全球标准化的护理，根据问卷和超声结果，提出了四种临床管理和监测方案。
